Ufp Technologies (UFPT) Non-Current Deffered Revenue (2015 - 2026)
Ufp Technologies' (UFPT) quarterly Non-Current Deffered Revenue came in at $6.7 million in Q2 2026, up 2.61% on a YoY basis from $6.5 million in Q2 2025, and down 0.76% quarter-over-quarter from $6.7 million in Q1 2026.
Analysis
Ufp Technologies (UFPT) Non-Current Deffered Revenue (2015 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has reported Non-Current Deffered Revenue for 12 consecutive years, with $6.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Deffered Revenue rose 2.61% year-over-year to $6.7 million; the trailing twelve-month figure through Jun 2026 stood at $6.7 million (up 2.61% YoY), and the FY2025 full-year result was $6.7 million, up 7.37% from the prior year.
- Non-Current Deffered Revenue retreated to $6.7 million in Q2 2026 per UFPT's latest filing, from $6.7 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $6.8 million in Q3 2025 and bottomed at $3.9 million in Q3 2022.
- Historically, Non-Current Deffered Revenue has averaged $5.6 million across 5 years, with a median of $5.8 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Non-Current Deffered Revenue declined 4.12% in 2022, then increased 28.86% in 2023.
- Over 5 years, Non-Current Deffered Revenue stood at $4.2 million in 2022, then climbed by 28.86% to $5.4 million in 2023, then climbed by 14.56% to $6.2 million in 2024, then gained by 7.37% to $6.7 million in 2025, then climbed by 0.53% to $6.7 million in 2026.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $6.7 million, $6.7 million, and $6.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | Ufp Technologies | 2.15 Bn | 2.14 Bn | 50.92 Mn | 6.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.69 Mn |
| Mar 31, 2026 | 6.74 Mn |
| Dec 31, 2025 | 6.66 Mn |
| Sep 30, 2025 | 6.78 Mn |
| Jun 30, 2025 | 6.52 Mn |
| Mar 31, 2025 | 6.44 Mn |
| Dec 31, 2024 | 6.20 Mn |
| Sep 30, 2024 | 6.17 Mn |
| Jun 30, 2024 | 5.82 Mn |
| Mar 31, 2024 | 5.71 Mn |
| Dec 31, 2023 | 5.41 Mn |
| Sep 30, 2023 | 4.89 Mn |
| Jun 30, 2023 | 5.00 Mn |
| Mar 31, 2023 | 4.75 Mn |
| Dec 31, 2022 | 4.20 Mn |
| Sep 30, 2022 | 3.89 Mn |
| Jun 30, 2022 | 4.05 Mn |
| Mar 31, 2022 | 4.46 Mn |
| Dec 31, 2021 | 4.34 Mn |
| Sep 30, 2021 | 4.05 Mn |